Water-soluble vitamin insufficiency, deficiency and supplementation in children and adolescents with a psychiatric disorder: a systematic review and meta-analysis

References

• Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients. J Nutr Health Aging. 2006;10:386–99.
   PubMed Web of Science ®Google Scholar
• Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J Nutr Health Aging. 2006;10:377–85.
   PubMed Web of Science ®Google Scholar
• Georgieff MK. Nutrition and the developing brain: nutrient priorities and measurement. Am J Clin Nutr. 2007;85:614S–20S.
   PubMed Web of Science ®Google Scholar
• John CC, Black MM, Nelson CA. Neurodevelopment: the impact of nutrition and inflammation during early to middle childhood in low-resource settings. Pediatrics. 2017;139:S59–71.
   PubMed Web of Science ®Google Scholar
• Nowakowski RS, Hayes NL. Developmental dyslexia: early precursors, neurobehavioral markers, and biological substrates. F. R. Baker W, Benasich A, editors. Baltimore: Brookes Publishing Co; 2012.
   Google Scholar
• Sowell ER, Trauner DA, Gamst A, Jernigan TL. Development of cortical and subcortical brain structures in childhood and adolescence: a structural MRI study. Dev Med Child Neurol. 2002;44:4–16.
   PubMed Web of Science ®Google Scholar
• John CC, Black MM, Nelson III CA. Neurodevelopment: The impact of nutrition and inflammation during early to middle childhood in low resource settings. Pediatrics. 2017;139(Suppl 1):S59–71.
   PubMed Web of Science ®Google Scholar
• Galler JR, Koethe JR, Yolken RH. Neurodevelopment: the impact of nutrition and inflammation during adolescence in low-resource settings. Pediatrics. 2017;139(Suppl 1):S72–84.
   PubMedGoogle Scholar
• Lieberman M, Marks AD, Peet A. Marks’ basic medical biochemistry: a clinical approach. Philadelphia (PA): Wolters Kluwer Health/Lippincott Williams & Wilkins; 2013.
   Google Scholar
• Devalia V, Hamilton MS, Molloy AM. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166:496–513. doi:10.1111/bjh.12959.
   PubMed Web of Science ®Google Scholar
• Stabler SP. Vitamin B12 deficiency. New Engl J Med. 2013;368:149–60. doi:10.1056/NEJMcp1113996.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Fortify your knowledge about vitamins. [Online]. Available: https://www.fda.gov/consumers/consumer-updates/fortify-your-knowledge-about-vitamins. [Accessed: 03-May-2019].
   Google Scholar
• European Food Safety Authority. Dietary Reference Values. Summary report EFSA Supporting publication, 2017. doi:10.2903/sp.efsa.2017.e15121.
   Google Scholar
• Kennedy DO. B vitamins and the brain: mechanisms, dose and efficacy—a review. Nutrients. 2016;8(2):68.
   PubMed Web of Science ®Google Scholar
• Brown HE, Roffman JL. Vitamin supplementation in the treatment of schizophrenia. CNS Drugs. 2014;28:611–22.
   PubMed Web of Science ®Google Scholar
• Smythies JR, Alarcon RD, Bancroft AJ, Monti JA, Morere DA, Tolbert LC. Walter-Ryan WG. Role of the one-carbon cycle in neuropsychiatry. Biological methylation and drug design. New York: Springer; 1986.
   Google Scholar
• Bertoglio K, James SJ, Deprey L, Brule N, Hendren RL. Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures in children with autism. J Altern Complement Med. 2010;16:555–60.
   PubMed Web of Science ®Google Scholar
• Kocot J, Luchowska-Kocot D, Kiełczykowska M, Musik I, Kurzepa J. Does vitamin C influence neurodegenerative diseases and psychiatric disorders? Nutrients. 2017;9:659. doi:10.3390/nu9070659.
   PubMed Web of Science ®Google Scholar
• Bajpai A, Verma AK, Srivastava M, Srivastava R. Oxidative stress and major depression. J Clin Diagn Res. 2014;8:CC04–CC07. doi:10.7860/JCDR/2014/10258.5292.
   PubMedGoogle Scholar
• Gautam M, Agrawal M, Gautam M, Sharma P, Gautam AS, Gautam S. Role of antioxidants in generalised anxiety disorder and depression. Indian J Psychiatry. 2012;54:244–7. doi:10.4103/0019-5545.102424.
   PubMedGoogle Scholar
• Plevin D, Galletly C. The neuropsychiatric effects of vitamin C deficiency: a systematic review. BMC Psychiatry. 2020;20:315. doi:10.1186/s12888-020-02730-w.
   PubMed Web of Science ®Google Scholar
• Arroll MA, Wilder L, Neil J. Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review. Nutr J. 2014;13:91.
   PubMed Web of Science ®Google Scholar
• Trincado J, Caneo C. Is augmentation with folate effective for major depressive disorder? Medwave. 2018;18:e7155–e7155.
   Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. doi:10.1371/journal.pmed.1000097.
   PubMed Web of Science ®Google Scholar
• Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
   Google Scholar
• Kennedy CE, Fonner VA, Armstrong KA, Denison JA, Yeh PT, O’Reilly KR, Sweat MD. The Evidence Project risk of bias tool: assessing study rigor for both randomized and non-randomized intervention studies. Syst Rev. 2019;8:3. doi:10.1186/s13643-018-0925-0.
   PubMed Web of Science ®Google Scholar
• Guo M, Li L, Zhang Q, Chen L, Dai Y, Liu L, et al. Vitamin and mineral status of children with autism spectrum disorder in Hainan Province of China: associations with symptoms. Ntr Neurosci. 2018;23(10):803–10. doi:10.1080/1028415X.2018.1558762.
   PubMed Web of Science ®Google Scholar
• Meguid NA, Anwar M, Bjørklund G, Hashish A, Chirumbolo S, Hemimi M, et al. Dietary adequacy of Egyptian children with autism spectrum disorder compared to healthy developing children. Metab Brain Dis. 2017;32:607–15.
   PubMed Web of Science ®Google Scholar
• Main PAE, Thomas P, Angley MT, Young R, Esterman A, King CE, et al. Lack of evidence for genomic instability in autistic children as measured by the cytokinesis-block micronucleus cytome assay. Autism Res. 2015;8:94–104.
   PubMed Web of Science ®Google Scholar
• Altun H, Kurutaş EB, Şahin N, Güngör O, Fındıklı E. The levels of vitamin D, vitamin D receptor, homocysteine and complex B vitamin in children with autism spectrum disorders. Clin Psychopharmacol Neurosci. 2018;16:383–90. doi:10.9758/cpn.2018.16.4.383.
   PubMed Web of Science ®Google Scholar
• Yektaş Ç, Alpay M, Tufan AE. Comparison of serum B12, folate and homocysteine concentrations in children with autism spectrum disorder or attention deficit hyperactivity disorder and healthy controls. Neuropsychiatr Dis Treat. 2019;15:2213–19.
   PubMed Web of Science ®Google Scholar
• Scaglione F, Panzavolta G. Folate, folic acid and 5-methyltetrahydrofolate are not the same thing. Xenobiotica. 2014;44:480–8.
   PubMed Web of Science ®Google Scholar
• Lamers Y. Indicators and methods for folate, vitamin B-12, and vitamin B-6 status assessment in humans. Curr Opin Clin Nutr Metab Care. 2011;14:445–54.
   PubMed Web of Science ®Google Scholar
• Shils CR ME, Shike M, Ross AC, Caballero B. Modern nutrition in health and disease. 10th ed. Baltimore (MD): Lippincot Williams and Wilkins; 2006.
   Google Scholar
• Ali A, Waly MI, Al-Farsi YM, Essa MM, Al-Sharbati MM, Deth RC. Hyperhomocysteinemia among Omani autistic children: a case-control study. Acta Biochim Pol. 2011;58:547–51.
   PubMed Web of Science ®Google Scholar
• Al-Farsi YM, Waly MI, Deth RC, Al-Sharbati MM, Al-Shafaee M, Al-Farsi O, Al-Khaduri MM, et al. Low folate and vitamin B12 nourishment is common in Omani children with newly diagnosed autism. Nutrition. 2013;29:537–41.
   PubMed Web of Science ®Google Scholar
• Sun C, Zou M, Zhao D, Xia W, Wu L. Efficacy of folic acid supplementation in autistic children participating in structured teaching: An open-label trial. Nutrients. 2016;8:337. doi:10.3390/nu8060337.
   PubMed Web of Science ®Google Scholar
• Liu X, Liu J, Xiong X, Yang T, Hou N, Liang X, et al. Correlation between nutrition and symptoms: nutritional survey of children with autism spectrum disorder in Chongqing, China. Nutrients. 2016;8:294. doi:10.3390/nu8050294.
   PubMed Web of Science ®Google Scholar
• Esnafoglu E, Ozturan DD. The relationship of severity of depression with homocysteine, folate, vitamin B12, and vitamin D levels in children and adolescents. Child Adolesc Ment Health. 2020;25:249–55. doi:10.1111/camh.12387.
   PubMed Web of Science ®Google Scholar
• Uğur Ç, Gürkan CK. Serum vitamin D and folate levels in children with autism spectrum disorders. Res Autism Spectr Disord. 2014;8:1641–7.
   Web of Science ®Google Scholar
• Zenger F, Russmann S, Junker E, Wüthrich C, Bui MH, Lauterburg BH. Decreased glutathione in patients with anorexia nervosa. Risk factor for toxic liver injury? Eur J Clin Nutrition. 2004;58:238–43.
   PubMed Web of Science ®Google Scholar
• Paşca SP, Dronca E, Kaucsár T, Craciun EC, Endreffy E, Ferencz BK, et al. One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders. J Cell Mol Med. 2009;13:4229–38.
   PubMed Web of Science ®Google Scholar
• Tsuchimine S, Saito M, Kaneko S, Yasui-Furukori N. Decreased serum levels of polyunsaturated fatty acids and folate, but not brain-derived neurotrophic factor, in childhood and adolescent females with depression. Psychiatry Res. 2015;225:187–90.
   PubMed Web of Science ®Google Scholar
• Esnafoğlu E, Yaman E. Vitamin B12, folic acid, homocysteine and vitamin D levels in children and adolescents with obsessive compulsive disorder. Psychiatry Res. 2017;254:232–7.
   PubMed Web of Science ®Google Scholar
• Melnyk S, Fuchs GJ, Schulz E, Lopez M, Kahler SG, Fussell JJ, et al. Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism. J Autism Dev Disord. 2013;42:367–77.
   Web of Science ®Google Scholar
• Altun H, Sahin N, Kurutaú EB, Güngör O. Homocysteine, pyridoxine, folate and vitamin b12 levels in children with attention deficit hyperactivity disorder. Psychiatr Danub. 2018;30:310–16.
   PubMed Web of Science ®Google Scholar
• Eto I, Bandy MD, Butterworth Jr. CE. Plasma and urinary levels of biopterin, neopterin, and related pterins and plasma levels of folate in infantile autism. J Autism Dev Disord. 1992;22:295–308. doi:10.1007/BF01058157.
   PubMed Web of Science ®Google Scholar
• Kevere L, Purvina S, Bauze D, Zeibarts M, Andrezina R, Piekuse L, et al. Homocysteine and MTHFR C677T polymorphism in children and adolescents with psychotic and mood disorders. Informa Healthcare. 2014;68:129–36. doi:10.3109/08039488.2013.782066.
   Google Scholar
• Robinson SL, Marín C, Oliveros H, Mora-Plazas M, Richards BJ, Lozoff B, et al. Iron deficiency, anemia, and low vitamin B-12 serostatus in middle childhood are associated with behavior problems in adolescent boys: results from the Bogotá School Children Cohort. J Nutr. 2018;8(148):760–70.
   Google Scholar
• Saha T, Chatterjee M, Sinha S, Rajamma U, Mukhopadhyay K. Components of thefolate metabolic pathway and ADHD core traits: an exploration in eastern Indian probands. J Hum Genet. 2017;62:687–95.
   PubMed Web of Science ®Google Scholar
• Wang LJ, Yu YH, Fu ML, Yeh WT, Hsu JL, Yang YH, et al. Dietary profiles, nutritional biochemistry status, and attention-deficit/hyperactivity disorder: path analysis for a case-control study. J Clin Med. 2019;19:709. doi:10.3390/jcm8050709.
   Google Scholar
• Zou M, Sun C, Liang S, Sun Y, Li D, Li L, et al. Fisher discriminant analysis for classification of autism spectrum disorders based on folate-related metabolism markers. J Nutr Biochem. 2019;64:25–31.
   PubMed Web of Science ®Google Scholar
• Unal D, Çelebi F, Bildik HN, Koyuncu A, Karahan S. Vitamin B12 and haemoglobin levels may be related with ADHD symptoms: a study in Turkish children with ADHD. Psych Clin Psychopharmacol. 2019;29:515–19.
   Web of Science ®Google Scholar
• Hope S, Naerland T, Høiland AL, Torske T, Malt E, Abrahamsen T, et al. Higher vitamin B12 levels in neurodevelopmental disorders than in healthy controls and schizophrenia A comparison among participants between 2 and 53 years. FASEB J. 2020;34(6):8114–24. doi:10.1096/fj.201900855RRR.
   PubMed Web of Science ®Google Scholar
• Kazanci SY, Saglam NO, Omar RH. Vitamin B12 <300 pg/mL in children and especially adolescents may predispose forgetfulness, anxiety, and unhappiness. Iran J Pediatr. 2017;27:e4663. doi:10.5812/ijp.4663.
   Web of Science ®Google Scholar
• Bala KA, Doǧan M, Kaba S, Mutluer T, Aslan O, Doǧan SZ. Hormone disorder and vitamin deficiency in attention deficit hyperactivity disorder (ADHD) and autism spectrum disorders (ASDs). J Pediatr Endocrinol Metab. 2016;29:1077–82.
   PubMed Web of Science ®Google Scholar
• Garipardic M, Doğan M, Bala KA, Mutluer T, Kaba S, Aslan O, et al. Association of attention deficit hyperactivity disorder and autism spectrum disorders with mean platelet volume and vitamin D. Med Sci Monit. 2017;23:1378–84.
   PubMed Web of Science ®Google Scholar
• Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, et al. Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab (Lond). 2011;8:34.
   PubMed Web of Science ®Google Scholar
• Dolske M, Spollen J, McKay S, Lancashire E, Tolbert L. A preliminary trial of ascorbic acid as supplemental therapy for autism. Prog Neuro-Psychopharmacol Biol Psychiat. 1993;17:765–74.
   PubMed Web of Science ®Google Scholar
• Adams JB, George F, Audhya T. Abnormally high plasma levels of vitamin B6 in children with autism not taking supplements compared to controls not taking supplements. J Altern Complement Med. 2006;12:59–63.
   PubMed Web of Science ®Google Scholar
• Al-Gadani Y, El-Ansary A, Attas O, Al-Ayadhi L. Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clin Biochem. 2009;42:1032–40.
   PubMed Web of Science ®Google Scholar
• Anwar A, Marini M, Abruzzo PM, Bolotta A, Ghezzo A, Visconti P, et al. Quantitation of plasma thiamine, related metabolites and plasma protein oxidative damage markers in children with autism spectrum disorder and healthy controls. Free Radic Res. 2016;50:S85–90.
   PubMed Web of Science ®Google Scholar
• Krajcovicova-Kudlackova M, Valachovicova M, Mislanova C, Hudecova Z, Sustrova M, Ostatnikova D. Plasma concentrations of selected antioxidants in autistic children and adolescents. Bratisl Lek Listy. 2009;110:247–50.
   PubMed Web of Science ®Google Scholar
• Sun C, Xia W, Zhao Y, Li N, Zhao D, Wu L. Nutritional status survey of children with autism and typically developing children aged 4–6 years in Heilongjiang Province, China. Nutr Sci. 2013;2:e16.
   PubMedGoogle Scholar
• Lonsdale D, Shamberger RJ, Audhya T. Treatment of autism spectrum children with thiamine tetrahydrofurfuryl disulfi de: a pilot study. Neuroendocrinol Lett. 2002;23:303–8.
   PubMed Web of Science ®Google Scholar
• James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, et al. Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr. 2009;89:425–30.
   PubMed Web of Science ®Google Scholar
• Frye RE, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, et al. Effectiveness of methylcobalamin and folinic acid treatment on adaptive behavior in children with autistic disorder is related to glutathione redox status. Autism Res Treat. 2013;2013:609705. doi:10.1155/2013/609705.
   PubMedGoogle Scholar
• Hendren RL, James SJ, Widjaja F, Lawton B, Rosenblatt A, Bent S. Randomized, placebo-controlled trial of methyl B12 for children with autism. J Child Adolesc Psychopharmacol. 2016;26:774–83.
   PubMed Web of Science ®Google Scholar
• Frye RE, Slattery J, Delhey L, Furgerson B, Strickland T, Tippett M, et al. Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. Mol Psychiatry. 2018;23:247–56.
   PubMed Web of Science ®Google Scholar
• James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. 2004;80:1611–17.
   PubMed Web of Science ®Google Scholar
• Kuriyama S, Kamiyama M, Watanabe M, Tamahashi S, Muraguchi I, Watanabe T, et al. Pyridoxine treatment in a subgroup of children with pervasive developmental disorders. Dev Med Child Neurol. 2002;44:284–6.
   PubMed Web of Science ®Google Scholar
• Hyman SL, Stewart PA, Schmidt B, Cain U, Lemcke N, Foley JT, et al. Nutrient intake from food in children with autism. Pediatrics. 2012;130:S145–53.
   PubMed Web of Science ®Google Scholar
• Johnson CR, Handen BL, Mayer-Costa M, Sacco K. Eating habits and dietary status in young children with autism. J Dev Phys Disabil. 2008;20:437–48.
   Web of Science ®Google Scholar
• Lockner DW, Crowe TK, Skipper BJ. Dietary intake and parents’ perception of mealtime behaviors in preschool-age children with autism spectrum disorder and in typically developing children. J Am Diet Assoc. 2008;108:1360–3.
   PubMedGoogle Scholar
• Incecik F, Hergüner MO, Altunbaşak S, Leblebisatan G. Neurologic findings of nutritional vitamin B12 deficiency in children. Turk J Pediatr. 2010 Jan-Feb;52(1):17–21.
   PubMed Web of Science ®Google Scholar
• Stover PJ. Vitamin B12 and older adults. Curr Opin Clin Nutr Metab Care. 2010 Jan;13(1):24–7.
   PubMed Web of Science ®Google Scholar
• Zhang Y. Decreased brain levels of vitamin B12 in aging, autism and chizophrenia. PLoS One. 2016;11(1):e0146797. doi:10.1371/journal.pone.0146797.
   PubMed Web of Science ®Google Scholar
• Alfawaz H, Bhat RS, Al-Mutairi M, Alnakhli OM, Al-Dbass A, AlOnazi M, et al. Comparative study on the independent and combined effects of omega-3 and vitamin B12 on phospholipids and phospholipase A2 as phospholipid hydrolyzing enzymes in PPA-treated rats as a model for autistic traits. Lip Health Dis. 2018;7:205. doi:10.1186/s12944-018-0850-1.
   Google Scholar
• Wang M, Li K, Zhao D, Li L. The association between maternal use of folic acid supplements during pregnancy and risk of autism spectrum disorders in children: a meta-analysis. Mol Autism. 2017;8:51. doi:10.1186/s13229-017-0170-8.
   PubMed Web of Science ®Google Scholar
• Raghavan R, Riley AW, Volk H, Caruso D, Hironaka L, Sices L, et al. Maternal multivitamin intake, plasma folate and vitamin B12 levels and autism spectrum disorder risk in offspring. Paediatr.Perinat Epidemiol. 2018;32:100–11.
   PubMed Web of Science ®Google Scholar
• Nye C, Brice A. Combined vitamin B6-magnesium treatment in autism spectrum disorder (review). Coch Database Syst Rev. 2005;4:CD003497. doi:10.1002/14651858.CD003497.pub2.
   Google Scholar
• James SJ. Autism and folate-dependent one-carbon metabolism: serendipity and critical branch-point decisions in science. Glob Adv Heal Med. 2013;2:48–51.
   PubMedGoogle Scholar
• Allen LH, Miller JW, de Groot L, Rosenberg IH, Smith AD, Refsum H, Raiten DJ. Biomarkers of nutrition for development (BOND): vitamin B-12 review. J Nutr. 2018;148(suppl_4):1995S–2027S. doi:10.1093/jn/nxy201.
   PubMed Web of Science ®Google Scholar
• Black MM. Effects of vitamin B12 and folate deficiency on brain development in children. Food Nutr Bull. 2008;29:S126–S131.
   PubMed Web of Science ®Google Scholar
• Zhong C, Tessing J, Lee BK, Lyall K. Maternal dietary factors and the risk of autism spectrum disorders: a systematic review of existence evidence. Autism Res. 2020;13:1634–58. doi:10.1002/aur.2402.
   PubMed Web of Science ®Google Scholar
• D’Souza B, D’Souza V. Oxidative injury and antioxidant vitamins E and C in schizophrenia. Ind J Clin Biochem. 2003;18:87–90.
   PubMedGoogle Scholar
• Pangrazzi L, Balasco L, Bozzi Y. Oxidative stress and immune system dysfunction in autism spectrum disorders. Int J Mol Sci. 2020;21:3293. doi:10.3390/ijms21093293.
   PubMed Web of Science ®Google Scholar
• Dakhale GN, Khanzode SD, Khanzode SS, Saoji A. Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia. Psychophramacology. 2005;182:494–8.
   PubMed Web of Science ®Google Scholar
• Ranjan S, Nasser JA. Nutritional status of individuals with autism spectrum disorders: do we know enough? Adv Nutr. 2015;6:397–407.
   PubMed Web of Science ®Google Scholar
• Karababa IF, Savas SN, Selek S, Cicek E, Cicek EI, Asoglu M, et al. Homocysteine levels and oxidative stress parameters in patients with adult ADHD. J Atten Disord. 2017;21(6):487–93.
   PubMed Web of Science ®Google Scholar
• Landaas ET, Aarsland TIM, Ulvik A, Halmøy A, Ueland PM, Haavik J. Vitamin levels in adults with ADHD. BJPsych Open. 2016;2:377–84. doi:10.1192/bjpo.bp.116.003491.
   PubMedGoogle Scholar
• Venkatramanan S, Armata IE, Strupp BJ, Finkelstein JL. Vitamin B-12 and cognition in children. Adv Nutr. 2016;7:879–88. doi:10.3945/an.115.012021.
   PubMed Web of Science ®Google Scholar
• Kvestad I, Hysing M, Shrestha M, Ulak M, Thorne-Lyman AL, Henjum S, et al. Vitamin B-12 status in infancy is positively associated with development and cognitive functioning 5 y later in Nepalese children. Am J Clin Nutr. 2017;105(5):1122–31. doi:10.3945/ajcn.116.144931.
   PubMed Web of Science ®Google Scholar
• Surman C, Ceranoglu A, Vaudreuil C, Albright B, Uchida M, Yule A, et al. Does L-methylfolate supplement methylphenidate pharmacotherapy in attention-deficit/hyperactivity disorder?: Evidence of lack of benefit from a double-blind, placebo-controlled, randomized clinical trial. J Clin Psychopharmacol. 2018;39:28–38.
   Web of Science ®Google Scholar
• Varela E, de Castro C, Espinosa L, Solerdelcoll M, Sugranyes G, Morer A, et al. Folic acid and vitamin B12 deficit in children and adolescents hospitalized due to a psychiatric disorder. Rev Psiquiatr Infanto-Juvenil. 2017;3:309–13. Spanish.
   Google Scholar
• Muntjewerff JW, Kahn RS, Blom HJ, den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry. 2006;11:143–9.
   PubMed Web of Science ®Google Scholar
• Roffman JL, Brohawn DG, Nitenson AZ, Macklin EA, Smoller JW, Goff DC. Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia. Schizophr Bull. 2013;39:330–8.
   PubMed Web of Science ®Google Scholar
• Gilbody S, Lightfoot T, Sheldon T. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemio Community Heal. 2007;61:631–7.
   PubMed Web of Science ®Google Scholar
• Anmella G, Varela E, Murru A, Hidalgo-Mazzei D, Prades N, Giménez A, et al. Vitamin B9 and B12 status in child and adolescent psychiatric inpatients. Submitted to Revista de Psiquiatría y Salud Mental.
   Google Scholar
• Seppälä J, Koponen H, Kautiainen H, Eriksson JG, Kampman O, Leiviskä J, et al. Association between vitamin B12 levels and melancholic depressive symptoms: a Finnish population-based study. BMC Psychiatry. 2013;13:145. doi:10.1186/1471-244X-13-145.
   PubMed Web of Science ®Google Scholar
• Hintikka J, Tolmunen T, Tanskanen A, Viinamäki H. High vitamin B12 level and good treatment outcome may be associated in major depressive disorder. BMC Psychiatry. 2003;3:17. doi:10.1186/1471-244X-3-17.
   PubMed Web of Science ®Google Scholar
• Schefft C, Kilarski LL, Bschor T, Köhler S. Efficacy of adding nutritional supplements in unipolar depression: A systematic review and meta-analysis. Eur Neuropsychopharmacol. 2017;27:1090–109.
   PubMed Web of Science ®Google Scholar
• de Koning EJ, van der Zwaluw NL, van Wijngaarden JP, Sohl E, Brouwer-Brolsma EM, van Marwijk HW, Enneman AW, et al. Effects of two-year vitamin B12 and folic acid supplementation on depressive symptoms and quality of life in older adults with elevated homocysteine concentrations: additional results from the B-PROOF study, an RCT. Nutrients. 2016;8:748. doi:10.3390/nu8110748.
   PubMed Web of Science ®Google Scholar
• Bottiglieri T, Reynolds EH, Laundy M. Folate in CSF and age. J Neurol Neurosurg Psychiatry. 2000;69:562.
   PubMed Web of Science ®Google Scholar
• Hermesh H, Weizman A, Shahar A, Munitz H. Vitamin B12 and folic acid serum levels in obsessive compulsive disorder. Acta Psychiatr Scand. 1988;78:8–10.
   PubMed Web of Science ®Google Scholar
• Türksoy N, Bilici R, Yalçiner A, Ozdemir O, Ornek I, Tufan AE, et al. Vitamin B12, folate, and homocysteine levels in patients with obsessive–compulsive disorder. Neuropsychiatr Dis Treat. 2014;10:1671–5.
   PubMed Web of Science ®Google Scholar
• Tural Ü, Çorapçıoğlu A, Boşgelmez Ş, Köroğlu G, Ünver H, Duman C, et al. Double blind controlled study of adding folic acid to fluoxetine in the treatment of OCD. Psychiatr Danub. 2019;31:69–77. doi:10.24869/psyd.2019.69.
   PubMed Web of Science ®Google Scholar
• FAO/WHO. Human vitamin and mineral requirements. Report of a joint FAO/WHO expert consultation Bangkok, Thailand, 2001.
   Google Scholar
• Sobczyńska-Malefora A, Delvin E, McCaddon A, Ahmadi KR, Harrington DJ. Vitamin B12 status in health and disease: a critical review. Diagnosis of deficiency and insufficiency – clinical and laboratory pitfalls. Crit Rev Clin Lab Sci. 2021 Apr 21;58(6):399–429. doi:10.1080/10408363.2021.1885339.
   PubMed Web of Science ®Google Scholar
• Vildoso M. Nutritional effects of anticonvulsants. Medwave. 2009;9:e3857. doi:10.5867/medwave.2009.04.3857.
   Google Scholar